
Silk Road Medical, Inc – NASDAQ:SILK
Silk Road Medical stock price monthly change
Silk Road Medical stock price quarterly change
Silk Road Medical stock price yearly change
Silk Road Medical key metrics
Market Cap | 1.11B |
Enterprise value | 1.43B |
P/E | -25.75 |
EV/Sales | 10.37 |
EV/EBITDA | -28.78 |
Price/Sales | 10.23 |
Price/Book | 8.65 |
PEG ratio | 3.70 |
EPS | -1.37 |
Revenue | 185.48M |
EBITDA | -49.35M |
Income | -53.41M |
Revenue Q/Q | 20.81% |
Revenue Y/Y | 23.04% |
Profit margin | -39.68% |
Oper. margin | -37.51% |
Gross margin | 72.68% |
EBIT margin | -37.51% |
EBITDA margin | -26.61% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeSilk Road Medical stock price history
Silk Road Medical stock forecast
Silk Road Medical financial statements
Jun 2023 | 45.29M | -13.48M | -29.77% |
---|---|---|---|
Sep 2023 | 44.43M | -12.78M | -28.78% |
Dec 2023 | 47.27M | -13.01M | -27.52% |
Mar 2024 | 48.48M | -14.13M | -29.16% |
Mar 2024 | 48.48M | -14.13M | -29.16% |
---|---|---|---|
Sep 2025 | 55.15M | -11.81M | -21.41% |
Oct 2025 | 54.43M | -11.68M | -21.46% |
Dec 2025 | 58.43M | -10.89M | -18.65% |
Analysts Price target
Financials & Ratios estimates
Jun 2023 | 263360000 | 107.85M | 40.95% |
---|---|---|---|
Sep 2023 | 260864000 | 107.72M | 41.29% |
Dec 2023 | 265309000 | 114.15M | 43.03% |
Mar 2024 | 252314000 | 105.02M | 41.63% |
Jun 2023 | -4.61M | -19.15M | 1.59M |
---|---|---|---|
Sep 2023 | -6.79M | 7.45M | 130K |
Dec 2023 | -8.45M | -1.58M | 1.05M |
Mar 2024 | -15.32M | 17.74M | 0 |
Silk Road Medical alternative data
Aug 2023 | 414 |
---|---|
Sep 2023 | 414 |
Oct 2023 | 414 |
Nov 2023 | 414 |
Dec 2023 | 414 |
Jan 2024 | 414 |
Feb 2024 | 414 |
Mar 2024 | 474 |
Apr 2024 | 474 |
May 2024 | 474 |
Jun 2024 | 474 |
Jul 2024 | 474 |
Silk Road Medical other data
Period | Buy | Sel |
---|---|---|
Aug 2023 | 0 | 8126 |
Oct 2023 | 0 | 3318 |
Jul 2024 | 0 | 66 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Sale | DAVIS ANDREW S. officer: Chief Commercial Officer | Common Stock | 66 | $27 | $1,782 | ||
Sale | JONES MARIE L. officer: CAO and VP, Finance | Common Stock | 656 | $6.61 | $4,334 | ||
Sale | BUCHANAN LUCAS W. officer: COO/CFO | Common Stock | 2,662 | $15.22 | $40,524 | ||
Sale | KLEMZ KEVIN M officer: EVP/Chief Legal Office.. | Common Stock | 1,539 | $20.11 | $30,942 | ||
Sale | DAVIS ANDREW S. officer: Chief Commercial Officer | Common Stock | 6,587 | $22.13 | $145,797 | ||
Option | BUCHANAN LUCAS W. officer: COO/CFO | Common Stock | 2,000 | $20 | $40,000 | ||
Option | BUCHANAN LUCAS W. officer: COO/CFO | Common Stock | 7,643 | $1.6 | $12,229 | ||
Option | BUCHANAN LUCAS W. officer: COO/CFO | Option (right to buy) | 2,000 | $20 | $40,000 | ||
Option | BUCHANAN LUCAS W. officer: COO/CFO | Option (right to buy) | 7,643 | $1.6 | $12,229 | ||
Option | JONES MARIE L. officer: CAO and VP, Finance | Common Stock | 2,000 | $6.11 | $12,220 |
Patent |
---|
Grant Filling date: 12 Mar 2019 Issue date: 6 Sep 2022 |
Grant Utility: Suture delivery device Filling date: 16 Jul 2019 Issue date: 19 Jul 2022 |
Application Filling date: 9 Sep 2021 Issue date: 30 Jun 2022 |
Grant Filling date: 8 Apr 2019 Issue date: 21 Jun 2022 |
Grant Filling date: 21 Feb 2019 Issue date: 21 Jun 2022 |
Grant Utility: Transcarotid neurovascular catheter Filling date: 19 Aug 2019 Issue date: 5 Apr 2022 |
Application Filling date: 10 Aug 2021 Issue date: 17 Feb 2022 |
Application Filling date: 19 Aug 2021 Issue date: 10 Feb 2022 |
Application Filling date: 4 May 2021 Issue date: 21 Oct 2021 |
Grant Utility: Fenestrated sheath for embolic protection during transcarotid carotid artery revascularization Filling date: 26 Oct 2018 Issue date: 12 Oct 2021 |
Quarter | Transcript |
---|---|
Q1 2024 30 Apr 2024 | Q1 2024 Earnings Call Transcript |
Q4 2023 28 Feb 2024 | Q4 2023 Earnings Call Transcript |
Q3 2023 9 Nov 2023 | Q3 2023 Earnings Call Transcript |
Q2 2023 1 Aug 2023 | Q2 2023 Earnings Call Transcript |
Silk Road Medical: Speculative Appeal Is Seen Here
Silk Road Medical: Big Nearby Cap-Gain Medical Equipment Stock Prospect
Silk Road Medical: Today Best Nearby Cap-Gain Medical Equipment Stock Prospect
Silk Road Medical: Revise To Buy As TCAR Procedural Volume Ramps Up
ShockWave Medical: A Hidden Gem In The Medical Device Sector
Silk Road Medical - What A Road It Has Been
-
When is Silk Road Medical's next earnings date?
Unfortunately, Silk Road Medical's (SILK) next earnings date is currently unknown.
-
Does Silk Road Medical pay dividends?
No, Silk Road Medical does not pay dividends.
-
How much money does Silk Road Medical make?
Silk Road Medical has a market capitalization of 1.11B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 27.77% to 177.13M US dollars.
-
What is Silk Road Medical's stock symbol?
Silk Road Medical, Inc is traded on the NASDAQ under the ticker symbol "SILK".
-
What is Silk Road Medical's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Silk Road Medical?
Shares of Silk Road Medical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Silk Road Medical's key executives?
Silk Road Medical's management team includes the following people:
- Mr. Lucas W. Buchanan Chief Financial Officer & Chief Operating Officer(age: 48, pay: $715,230)
- Mr. Andrew S. Davis Chief Commercial Officer(age: 56, pay: $655,830)
- Ms. Erica J. Rogers Pres, Chief Executive Officer & Director(age: 61, pay: $497,120)
- Mr. Richard M. Ruedy Executive Vice President of Clinical, Regulatory Affairs & Quality Assurance(age: 58, pay: $433,060)
-
How many employees does Silk Road Medical have?
As Jul 2024, Silk Road Medical employs 474 workers.
-
When Silk Road Medical went public?
Silk Road Medical, Inc is publicly traded company for more then 6 years since IPO on 4 Apr 2019.
-
What is Silk Road Medical's official website?
The official website for Silk Road Medical is silkroadmed.com.
-
Where are Silk Road Medical's headquarters?
Silk Road Medical is headquartered at 1213 Innsbruck Drive, Sunnyvale, CA.
-
How can i contact Silk Road Medical?
Silk Road Medical's mailing address is 1213 Innsbruck Drive, Sunnyvale, CA and company can be reached via phone at +40 87209002.
Silk Road Medical company profile:

Silk Road Medical, Inc
silkroadmed.comNASDAQ
474
Medical - Devices
Healthcare
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.
Sunnyvale, CA 94089
CIK: 0001397702
ISIN: US82710M1009
CUSIP: 82710M100